| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | 0.0054 | 0.9 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.0022 | 0.9 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.0023 | 0.9 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | -0.002 | 0.9 |